<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T19:11:23Z</responseDate>
  <request identifier="oai:figshare.com:article/33771667" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33771667</identifier>
        <datestamp>2026-09-15T05:34:08Z</datestamp>
        <setSpec>category_15</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Supplementary file 1_Long-term risk of incident dementia following documented COVID-19 among older adults with type 2 diabetes: a propensity score-matched cohort study.docx</dc:title>
          <dc:creator>I-Wen Chen (9548687)</dc:creator>
          <dc:creator>Li-Chen Chang (23595883)</dc:creator>
          <dc:creator>Chun-Ning Ho (14348433)</dc:creator>
          <dc:creator>Kuo-Chuan Hung (8587392)</dc:creator>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>cohort study</dc:subject>
          <dc:subject>COVID-19</dc:subject>
          <dc:subject>dementia</dc:subject>
          <dc:subject>propensity score matching</dc:subject>
          <dc:subject>TriNetX</dc:subject>
          <dc:subject>type 2 diabetes mellitus</dc:subject>
          <dc:description>Background&lt;p&gt;Type 2 diabetes mellitus (T2DM) is a well-established risk factor for dementia, and COVID-19 has been associated with persistent neurological and cognitive sequelae. However, whether this association extends beyond the early post-infection period among older adults with T2DM—a population with compounded vascular and metabolic vulnerability—remains unclear.&lt;/p&gt;Methods&lt;p&gt;Using the TriNetX Global Collaborative Network, we conducted a retrospective cohort study of patients aged ≥65 years with T2DM, comparing those with documented COVID-19 to a matched unexposed cohort (1:1 propensity score matching). A 1-year landmark design was applied, with follow-up extending to 6 years after the index date. The primary outcome was incident overall dementia, which is a composite of vascular dementia, Alzheimer’s disease, and unspecified/other dementia. The secondary outcomes included individual dementia subtypes, mild cognitive impairment, all-cause mortality, and cerebral infarction.&lt;/p&gt;Results&lt;p&gt;After matching, 449,745 patients were included in each group with well-balanced covariates (all standardized mean differences &lt;0.1). Documented COVID-19 was associated with a significantly increased risk of overall dementia [hazard ratio (HR 1.51), 95% confidence interval (CI) 1.47–1.55, p &lt; 0.001]. The secondary outcomes were similarly elevated, such as vascular dementia (HR 1.61), Alzheimer’s disease (HR 1.41), mild cognitive impairment (HR 1.66), all-cause mortality (HR 1.56), and cerebral infarction (HR 1.33; all p &lt; 0.001). The hazard ratio for overall dementia increased progressively across sequential landmark periods (1.51 at 1 year, 1.66 at 2 years, and 2.09 at 3 years), and the findings remained robust across sensitivity analyses, addressing survival, healthcare utilization, and exposure misclassification. The findings were consistent in separately constructed and propensity score-matched additional cohorts restricted to adults aged 50–65 years and to patients indexed during the Omicron-predominant period.&lt;/p&gt;Conclusion&lt;p&gt;In this large propensity score-matched cohort study, documented COVID-19 was associated with an increased long-term risk of incident dementia among older adults with T2DM, with the association persisting and strengthening beyond the early post-infection period. These findings support sustained attention to cognitive health in this metabolically susceptible population following COVID-19; however prospective studies incorporating standardized cognitive and biomarker assessments are needed to clarify underlying causes.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-15T05:34:08Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fnagi.2026.1927383.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Supplementary_file_1_Long-term_risk_of_incident_dementia_following_documented_COVID-19_among_older_adults_with_type_2_diabetes_a_propensity_score-matched_cohort_study_docx/33771667</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
